The page of LASA. Captures the information on Price and Volume for the stock. It also contains the Live Stock Price and Volume, 52 Week High Low and Volume data.Intradaystock prediction for today 23-12-2024 is predicted based on technical analysis and should only be used as reference for learning purpose only.
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Morepen Lab | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Marksans Pharma | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kopran | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sequent Scienti | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, and halquinol, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.
| Company | LTP | Change | Gain |
|---|---|---|---|
| ICICI-Bank-Limited | 1288.4 | 1.5 | 0.12 % |
| Titan-Company | 3356.25 | -0.6 | -0.02 % |
| Company | LTP | Change | Loss |
|---|---|---|---|
| IndusInd-Bank | 929.45 | -34.95 | -3.62 % |
| Axis-Bank-Limited | 1071.85 | -37.05 | -3.34 % |
